Global Overactive Bladder Therapeutics Market Research Report 2023

SKU ID : QYR-23835086 | Publishing Date : 23-May-2023 | No. of pages : 88

Request a free Sample

Detailed TOC of Global Overactive Bladder Therapeutics Market Research Report 2023

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Overactive Bladder Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Anticholinergics
        1.2.3 Mirabegron
        1.2.4 Botox
    1.3 Market by Application
        1.3.1 Global Overactive Bladder Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Idiopathic Overactive Bladder
        1.3.3 Neurogenic Overactive Bladder
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Overactive Bladder Therapeutics Market Perspective (2018-2029)
    2.2 Overactive Bladder Therapeutics Growth Trends by Region
        2.2.1 Global Overactive Bladder Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Overactive Bladder Therapeutics Historic Market Size by Region (2018-2023)
        2.2.3 Overactive Bladder Therapeutics Forecasted Market Size by Region (2024-2029)
    2.3 Overactive Bladder Therapeutics Market Dynamics
        2.3.1 Overactive Bladder Therapeutics Industry Trends
        2.3.2 Overactive Bladder Therapeutics Market Drivers
        2.3.3 Overactive Bladder Therapeutics Market Challenges
        2.3.4 Overactive Bladder Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Overactive Bladder Therapeutics Players by Revenue
        3.1.1 Global Top Overactive Bladder Therapeutics Players by Revenue (2018-2023)
        3.1.2 Global Overactive Bladder Therapeutics Revenue Market Share by Players (2018-2023)
    3.2 Global Overactive Bladder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Overactive Bladder Therapeutics Revenue
    3.4 Global Overactive Bladder Therapeutics Market Concentration Ratio
        3.4.1 Global Overactive Bladder Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Overactive Bladder Therapeutics Revenue in 2022
    3.5 Overactive Bladder Therapeutics Key Players Head office and Area Served
    3.6 Key Players Overactive Bladder Therapeutics Product Solution and Service
    3.7 Date of Enter into Overactive Bladder Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Overactive Bladder Therapeutics Breakdown Data by Type
    4.1 Global Overactive Bladder Therapeutics Historic Market Size by Type (2018-2023)
    4.2 Global Overactive Bladder Therapeutics Forecasted Market Size by Type (2024-2029)
5 Overactive Bladder Therapeutics Breakdown Data by Application
    5.1 Global Overactive Bladder Therapeutics Historic Market Size by Application (2018-2023)
    5.2 Global Overactive Bladder Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Overactive Bladder Therapeutics Market Size (2018-2029)
    6.2 North America Overactive Bladder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Overactive Bladder Therapeutics Market Size by Country (2018-2023)
    6.4 North America Overactive Bladder Therapeutics Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Overactive Bladder Therapeutics Market Size (2018-2029)
    7.2 Europe Overactive Bladder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Overactive Bladder Therapeutics Market Size by Country (2018-2023)
    7.4 Europe Overactive Bladder Therapeutics Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Overactive Bladder Therapeutics Market Size (2018-2029)
    8.2 Asia-Pacific Overactive Bladder Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Overactive Bladder Therapeutics Market Size by Region (2018-2023)
    8.4 Asia-Pacific Overactive Bladder Therapeutics Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Overactive Bladder Therapeutics Market Size (2018-2029)
    9.2 Latin America Overactive Bladder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Overactive Bladder Therapeutics Market Size by Country (2018-2023)
    9.4 Latin America Overactive Bladder Therapeutics Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Overactive Bladder Therapeutics Market Size (2018-2029)
    10.2 Middle East & Africa Overactive Bladder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Overactive Bladder Therapeutics Market Size by Country (2018-2023)
    10.4 Middle East & Africa Overactive Bladder Therapeutics Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Astellas Pharma
        11.1.1 Astellas Pharma Company Detail
        11.1.2 Astellas Pharma Business Overview
        11.1.3 Astellas Pharma Overactive Bladder Therapeutics Introduction
        11.1.4 Astellas Pharma Revenue in Overactive Bladder Therapeutics Business (2018-2023)
        11.1.5 Astellas Pharma Recent Development
    11.2 Allergan
        11.2.1 Allergan Company Detail
        11.2.2 Allergan Business Overview
        11.2.3 Allergan Overactive Bladder Therapeutics Introduction
        11.2.4 Allergan Revenue in Overactive Bladder Therapeutics Business (2018-2023)
        11.2.5 Allergan Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Overactive Bladder Therapeutics Introduction
        11.3.4 Pfizer Revenue in Overactive Bladder Therapeutics Business (2018-2023)
        11.3.5 Pfizer Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Detail
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Overactive Bladder Therapeutics Introduction
        11.4.4 Johnson & Johnson Revenue in Overactive Bladder Therapeutics Business (2018-2023)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Teva (Activas)
        11.5.1 Teva (Activas) Company Detail
        11.5.2 Teva (Activas) Business Overview
        11.5.3 Teva (Activas) Overactive Bladder Therapeutics Introduction
        11.5.4 Teva (Activas) Revenue in Overactive Bladder Therapeutics Business (2018-2023)
        11.5.5 Teva (Activas) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Overactive Bladder Therapeutics Market Research Report 2023

List of Tables
    Table 1. Global Overactive Bladder Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Anticholinergics
    Table 3. Key Players of Mirabegron
    Table 4. Key Players of Botox
    Table 5. Global Overactive Bladder Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Overactive Bladder Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Overactive Bladder Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Overactive Bladder Therapeutics Market Share by Region (2018-2023)
    Table 9. Global Overactive Bladder Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Overactive Bladder Therapeutics Market Share by Region (2024-2029)
    Table 11. Overactive Bladder Therapeutics Market Trends
    Table 12. Overactive Bladder Therapeutics Market Drivers
    Table 13. Overactive Bladder Therapeutics Market Challenges
    Table 14. Overactive Bladder Therapeutics Market Restraints
    Table 15. Global Overactive Bladder Therapeutics Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Overactive Bladder Therapeutics Market Share by Players (2018-2023)
    Table 17. Global Top Overactive Bladder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Therapeutics as of 2022)
    Table 18. Ranking of Global Top Overactive Bladder Therapeutics Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Overactive Bladder Therapeutics Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Overactive Bladder Therapeutics Product Solution and Service
    Table 22. Date of Enter into Overactive Bladder Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Overactive Bladder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Overactive Bladder Therapeutics Revenue Market Share by Type (2018-2023)
    Table 26. Global Overactive Bladder Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Overactive Bladder Therapeutics Revenue Market Share by Type (2024-2029)
    Table 28. Global Overactive Bladder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Overactive Bladder Therapeutics Revenue Market Share by Application (2018-2023)
    Table 30. Global Overactive Bladder Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Overactive Bladder Therapeutics Revenue Market Share by Application (2024-2029)
    Table 32. North America Overactive Bladder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Overactive Bladder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Overactive Bladder Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Overactive Bladder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Overactive Bladder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Overactive Bladder Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Overactive Bladder Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Overactive Bladder Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Overactive Bladder Therapeutics Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Overactive Bladder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Overactive Bladder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Overactive Bladder Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Overactive Bladder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Overactive Bladder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Overactive Bladder Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Astellas Pharma Company Detail
    Table 48. Astellas Pharma Business Overview
    Table 49. Astellas Pharma Overactive Bladder Therapeutics Product
    Table 50. Astellas Pharma Revenue in Overactive Bladder Therapeutics Business (2018-2023) & (US$ Million)
    Table 51. Astellas Pharma Recent Development
    Table 52. Allergan Company Detail
    Table 53. Allergan Business Overview
    Table 54. Allergan Overactive Bladder Therapeutics Product
    Table 55. Allergan Revenue in Overactive Bladder Therapeutics Business (2018-2023) & (US$ Million)
    Table 56. Allergan Recent Development
    Table 57. Pfizer Company Detail
    Table 58. Pfizer Business Overview
    Table 59. Pfizer Overactive Bladder Therapeutics Product
    Table 60. Pfizer Revenue in Overactive Bladder Therapeutics Business (2018-2023) & (US$ Million)
    Table 61. Pfizer Recent Development
    Table 62. Johnson & Johnson Company Detail
    Table 63. Johnson & Johnson Business Overview
    Table 64. Johnson & Johnson Overactive Bladder Therapeutics Product
    Table 65. Johnson & Johnson Revenue in Overactive Bladder Therapeutics Business (2018-2023) & (US$ Million)
    Table 66. Johnson & Johnson Recent Development
    Table 67. Teva (Activas) Company Detail
    Table 68. Teva (Activas) Business Overview
    Table 69. Teva (Activas) Overactive Bladder Therapeutics Product
    Table 70. Teva (Activas) Revenue in Overactive Bladder Therapeutics Business (2018-2023) & (US$ Million)
    Table 71. Teva (Activas) Recent Development
    Table 72. Research Programs/Design for This Report
    Table 73. Key Data Information from Secondary Sources
    Table 74. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Overactive Bladder Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Overactive Bladder Therapeutics Market Share by Type: 2022 VS 2029
    Figure 3. Anticholinergics Features
    Figure 4. Mirabegron Features
    Figure 5. Botox Features
    Figure 6. Global Overactive Bladder Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Overactive Bladder Therapeutics Market Share by Application: 2022 VS 2029
    Figure 8. Idiopathic Overactive Bladder Case Studies
    Figure 9. Neurogenic Overactive Bladder Case Studies
    Figure 10. Overactive Bladder Therapeutics Report Years Considered
    Figure 11. Global Overactive Bladder Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Overactive Bladder Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Overactive Bladder Therapeutics Market Share by Region: 2022 VS 2029
    Figure 14. Global Overactive Bladder Therapeutics Market Share by Players in 2022
    Figure 15. Global Top Overactive Bladder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Therapeutics as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Overactive Bladder Therapeutics Revenue in 2022
    Figure 17. North America Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Overactive Bladder Therapeutics Market Share by Country (2018-2029)
    Figure 19. United States Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Overactive Bladder Therapeutics Market Share by Country (2018-2029)
    Figure 23. Germany Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Overactive Bladder Therapeutics Market Share by Region (2018-2029)
    Figure 31. China Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Overactive Bladder Therapeutics Market Share by Country (2018-2029)
    Figure 39. Mexico Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Overactive Bladder Therapeutics Market Share by Country (2018-2029)
    Figure 43. Turkey Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Astellas Pharma Revenue Growth Rate in Overactive Bladder Therapeutics Business (2018-2023)
    Figure 46. Allergan Revenue Growth Rate in Overactive Bladder Therapeutics Business (2018-2023)
    Figure 47. Pfizer Revenue Growth Rate in Overactive Bladder Therapeutics Business (2018-2023)
    Figure 48. Johnson & Johnson Revenue Growth Rate in Overactive Bladder Therapeutics Business (2018-2023)
    Figure 49. Teva (Activas) Revenue Growth Rate in Overactive Bladder Therapeutics Business (2018-2023)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed